Literature DB >> 22850488

Residual complaints after neuralgic amyotrophy.

Edith H Cup1, Jos Ijspeert, Renske J Janssen, Chaska Bussemaker-Beumer, Joost Jacobs, Allan J Pieterse, Harmen van der Linde, Nens van Alfen.   

Abstract

OBJECTIVE: To develop recommendations regarding outcome measures and topics to be addressed in rehabilitation for persons with neuralgic amyotrophy (NA), this study explored which functions and activities are related to persisting pain in NA and which questionnaires best capture these factors.
DESIGN: A questionnaire-based survey from 2 cross-sectional cohorts, one of patients visiting the neurology outpatient clinic and a cohort seen at a multidisciplinary plexus clinic.
SETTING: Two tertiary referral clinics based in the Department of Neurology and Rehabilitation from a university medical center provided the data. PARTICIPANTS: A referred sample of patients (N=248) with either idiopathic or hereditary NA who fulfilled the criteria for this disorder, in whom the last episode of NA had been at least 6 months ago and included brachial plexus involvement.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Two custom clinical screening questionnaires were used as well as the Shoulder Rating Questionnaire-Dutch Language Version, the Shoulder Pain and Disability Index (SPADI), the Shoulder Disability Questionnaire (SDQ), and Overall Disability Sum Score.
RESULTS: The survey confirms the high prevalence of persisting pain and impairments. More than half of the patients were restricted by pain, while in those without pain 60% experienced residual paresis. Correlations show an intimate relation between pain, scapular instability, problems with overhead activities, and increased fatigability. A standard physical therapy approach was ineffective or aggravated symptoms in more than 50%.
CONCLUSIONS: Pain and fatigue are strongly correlated to persisting scapular instability and increased fatigability of the affected muscles in NA. Our results suggest that an integrated rehabilitation approach is needed in which all of these factors are addressed. We further recommend using the SPADI and SDQ in future studies to evaluate the natural course and treatment effects in NA.
Copyright © 2013 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22850488     DOI: 10.1016/j.apmr.2012.07.014

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Chiropractic management of a geriatric patient with idiopathic neuralgic amyotrophy: a case report.

Authors:  Jordan Gliedt; Justin M Goehl; Derek P Smith; Clinton J Daniels
Journal:  J Can Chiropr Assoc       Date:  2017-03

Review 2.  Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype.

Authors:  Quentin Scanvion; Thierry Perez; François Cassim; Olivier Outteryck; Aurélia Lanteri; Pierre-Yves Hatron; Marc Lambert; Sandrine Morell-Dubois
Journal:  J Neurol       Date:  2017-02-28       Impact factor: 6.682

3.  Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study.

Authors:  Nens van Alfen; Jeroen J J van Eijk; Tessa Ennik; Sean O Flynn; Inge E G Nobacht; Jan T Groothuis; Sigrid Pillen; Floris A van de Laar
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

4.  NA-CONTROL: a study protocol for a randomised controlled trial to compare specific outpatient rehabilitation that targets cerebral mechanisms through relearning motor control and uses self-management strategies to improve functional capability of the upper extremity, to usual care in patients with neuralgic amyotrophy.

Authors:  Renee Lustenhouwer; Nens van Alfen; Ian G M Cameron; Ivan Toni; Alexander C H Geurts; Rick C Helmich; Baziel G M van Engelen; Jan T Groothuis
Journal:  Trials       Date:  2019-08-07       Impact factor: 2.279

5.  Parsonage-Turner syndrome after COVID-19 infection.

Authors:  Thomas Gary Voss; Cory Michael Stewart
Journal:  JSES Rev Rep Tech       Date:  2022-01-13

6.  Visuomotor processing is altered after peripheral nerve damage in neuralgic amyotrophy.

Authors:  Renee Lustenhouwer; Ian G M Cameron; Elze Wolfs; Nens van Alfen; Ivan Toni; Alexander C H Geurts; Baziel G M van Engelen; Jan T Groothuis; Rick C Helmich
Journal:  Brain Commun       Date:  2022-02-16

7.  Reachable workspace analysis is a potential measurement for impairment of the upper extremity in neuralgic amyotrophy.

Authors:  Jos IJspeert; Renee Lustenhouwer; Renske M Janssen; Jay J Han; Maya N Hatch; Ian Cameron; Rick C Helmich; Baziel van Engelen; Philip van der Wees; Alexander C H Geurts; Nens van Alfen; Jan T Groothuis
Journal:  Muscle Nerve       Date:  2022-06-21       Impact factor: 3.852

8.  HEV-Associated Neuralgic Amyotrophy: A Multicentric Case Series.

Authors:  Johannes H Bannasch; Benjamin Berger; Claus-Peter Schwartkop; Marco Berning; Oliver Goetze; Marcus Panning; Miriam Fritz-Weltin; George Trendelenburg; Mathias Gelderblom; Marc Lütgehetmann; Fridrike Stute; Thomas Horvatits; Meike Dirks; Christoph Antoni; Patrick Behrendt; Sven Pischke
Journal:  Pathogens       Date:  2021-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.